Medicare Enrolled
Dr. Saro Kasparian, M.D.
Student in an Organized Health Care Education/Training Program · Glendale, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kasparian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kasparian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kasparian
Dr. Saro Kasparian is a student in an organized health care education/training program specialist in Glendale, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Kasparian performed 6,597 Medicare services across 1,242 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kasparian received a total of $9,213 from 56 pharmaceutical and/or device companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kasparian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years in practice
▲ Top 3% volume in CA
$9,213 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,597
Medicare services
Top 3% in CA for student in an organized health care education/training program
1,242
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~825 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,004 | $35 | $133 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,516 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 1,262 | $19 | $73 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $110 | $421 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
239 | $8 | $23 |
| Anti-nausea injection (Aloxi/palonosetron) | 164 | $1 | $3 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
123 | $4 | $17 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
108 | $26 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
93 | $1 | $2 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
86 | $100 | $381 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
81 | $18 | $70 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
77 | $10 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $78 | $298 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
69 | $59 | $225 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
56 | $121 | $463 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $12 | $48 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
39 | $25 | $98 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
37 | $31 | $118 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
30 | $59 | $226 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $154 | $590 |
| New patient office visit, complex (60-74 min) | 25 | $188 | $721 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $30 | $114 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $111 | $425 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
19 | $8 | $26 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
17 | $12 | $44 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $145 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.0% high complexity
47.8% medium
16.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,213
Total received (2021-2024)
Avg $2,303/year across 4 years
Top 4% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
322
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,809 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$404 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,330
2023
$2,076
2022
$278
2021
$529
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$664
Celgene Corporation
$382
Astellas Pharma US Inc
$370
Incyte Corporation
$359
Janssen Biotech, Inc.
$304
PFIZER INC.
$295
Merck Sharp & Dohme LLC
$292
E.R. Squibb & Sons, L.L.C.
$253
Lilly USA, LLC
$252
Eisai Inc.
$249
Novartis Pharmaceuticals Corporation
$224
Takeda Pharmaceuticals U.S.A., Inc.
$201
GENZYME CORPORATION
$157
ABBVIE INC.
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Genentech USA, Inc.
$141
Gilead Sciences, Inc.
$138
TerSera Therapeutics LLC
$132
Bayer Healthcare Pharmaceuticals Inc.
$118
Karyopharm Therapeutics Inc.
$112
SOBI, INC
$110
PharmaEssentia USA Corporation
$100
ADC Therapeutics America, Inc.
$97
Exelixis Inc.
$92
Pulmonx Corporation
$79
ARRAY BIOPHARMA INC
$75
Genmab U.S., Inc.
$64
EMD Serono, Inc.
$58
Alexion Pharmaceuticals, Inc.
$55
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
PUMA BIOTECHNOLOGY, INC.
$54
TAIHO ONCOLOGY, INC.
$52
Kite Pharma, Inc.
$49
Deciphera Pharmaceuticals Inc.
$47
JAZZ PHARMACEUTICALS INC.
$44
Mirati Therapeutics, Inc.
$41
Immunocore Limited
$34
Blueprint Medicines Corporation
$32
SpringWorks Therapeutics, Inc.
$30
Daiichi Sankyo Inc.
$30
Pharmacosmos Therapeutics Inc.
$29
Organon Llc
$28
GlaxoSmithKline, LLC.
$27
Adaptive Biotechnologies Corporation
$26
ImmunoGen, Inc.
$24
Coherus Biosciences Inc.
$22
Chiesi USA, Inc.
$19
Tempus AI, Inc
$14
Top 3 companies account for 22.4% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$855
Incyte Corporation
$597
Seagen Inc.
$491
Celgene Corporation
$465
Merck Sharp & Dohme LLC
$457
Astellas Pharma US Inc
$420
PFIZER INC.
$356
Janssen Biotech, Inc.
$324
E.R. Squibb & Sons, L.L.C.
$307
Lilly USA, LLC
$306
Takeda Pharmaceuticals U.S.A., Inc.
$298
Eisai Inc.
$298
Gilead Sciences, Inc.
$289
Genentech USA, Inc.
$263
GENZYME CORPORATION
$252
Exelixis Inc.
$247
Novartis Pharmaceuticals Corporation
$224
Bayer Healthcare Pharmaceuticals Inc.
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
PharmaEssentia USA Corporation
$156
ABBVIE INC.
$155
Karyopharm Therapeutics Inc.
$145
Janssen Scientific Affairs, LLC
$145
TerSera Therapeutics LLC
$132
SOBI, INC
$110
Deciphera Pharmaceuticals Inc.
$110
ARRAY BIOPHARMA INC
$106
ADC Therapeutics America, Inc.
$97
Genmab U.S., Inc.
$91
BeiGene USA, Inc.
$89
EMD Serono, Inc.
$82
Pulmonx Corporation
$79
Blueprint Medicines Corporation
$77
TAIHO ONCOLOGY, INC.
$74
Mirati Therapeutics, Inc.
$65
Alexion Pharmaceuticals, Inc.
$55
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
PUMA BIOTECHNOLOGY, INC.
$54
Kite Pharma, Inc.
$49
ImmunoGen, Inc.
$45
JAZZ PHARMACEUTICALS INC.
$44
Immunocore Limited
$34
SpringWorks Therapeutics, Inc.
$30
Daiichi Sankyo Inc.
$30
Pharmacosmos Therapeutics Inc.
$29
Organon Llc
$28
GlaxoSmithKline, LLC.
$27
Sumitomo Pharma America, Inc.
$26
Adaptive Biotechnologies Corporation
$26
SERVIER PHARMACEUTICALS LLC
$25
Puma Biotechnology, Inc.
$24
Coherus Biosciences Inc.
$22
AVEO Pharmaceuticals, Inc.
$21
Chiesi USA, Inc.
$19
Amgen Inc.
$16
Tempus AI, Inc
$14
Top 3 companies account for 21.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CHARTIS CATHETER · Columvi · DARZALEX · DOPTELET · ELAHERE · ELREXFIO · ENHERTU · ERLEADA · Elahere · Enhertu · Epkinly · FERRIPROX · FOTIVDA · FRUZAQLA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LONSURF · LOQTORZI · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORENCIA · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · Phesgo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · SARCLISA · SCEMBLIX · Stivarga · TAGRISSO · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vyloy · XALKORI · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for student in an organized health care education/training program in CA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
14,156
Per 100K population
143.7
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kasparian is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 4% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kasparian experienced with immune globulin infusion (octagam)?
Based on Medicare claims data, Dr. Kasparian performed 2,004 immune globulin infusion (octagam) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kasparian receive payments from pharmaceutical companies?
Yes. Dr. Kasparian received a total of $9,213 from 56 companies across 322 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kasparian's costs compare to other student in an organized health care education/training programs in Glendale?
Dr. Kasparian's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kasparian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Glendale
Browse student in an organized health care education/training programs in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology